Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Piramal Pharma Limited ( (IN:PPLPHARMA) ).
Piramal Pharma Limited has announced a series of senior leadership changes, expanding its cadre of Senior Management Personnel with the additional designation of Chief Quality Officer Rashida Najmi, President – Mergers and Acquisitions Jatin Lal, General Counsel Sandeep Rathod and Chief Human Resource Officer Puneet Rajput as senior management with immediate effect. In a concurrent change to its key managerial positions, Company Secretary and Compliance Officer Tanya Sanish has resigned effective 20 February 2026 to pursue opportunities outside the organisation, and the board has appointed Pratibha Mishra as Interim Company Secretary and Compliance Officer from 21 February 2026, signalling a continuity-focused transition in governance and compliance oversight for stakeholders.
More about Piramal Pharma Limited
Piramal Pharma Limited is an India-based pharmaceutical company engaged in the development, manufacture and distribution of pharmaceutical products and services. Listed on the BSE and NSE, the company operates across multiple segments of the pharma value chain and serves domestic and international markets from its Mumbai-headquartered operations.
Average Trading Volume: 222,676
Technical Sentiment Signal: Sell
Current Market Cap: 201.2B INR
For a thorough assessment of PPLPHARMA stock, go to TipRanks’ Stock Analysis page.